Changeflow GovPing Pharma & Drug Safety USPTO Patent Application: Oral Care Composition...
Routine Notice Added Draft

USPTO Patent Application: Oral Care Composition with Mint Oil and Tin

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published September 11th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083649A1) for an oral care composition. The invention involves a blend of mint oil, tin, and flavor extract designed to prevent the formation of methyl mercaptan, a compound that can cause unpleasant odors.

What changed

This document is a USPTO patent application (US20260083649A1) filed on September 11, 2025, for an oral care composition. The composition includes a natural flavor extract, a sulfur source, a stannous ion source, and a soluble metal ion source intended to prevent the formation of methyl mercaptan. The application details potential inventors and CPC classifications related to pharmaceutical and cosmetic preparations.

As this is a patent application, it does not impose immediate compliance obligations. However, it signals potential future product development and intellectual property in the oral care sector. Companies operating in this space should be aware of emerging patent filings that could impact their own product development or market strategies.

Source document (simplified)

← USPTO Patent Applications

ORAL CARE COMPOSITIONS COMPRISING MINT OIL AND TIN

Application US20260083649A1 Kind: A1 Mar 26, 2026

Inventors

Steven Hamilton HOKE, II, George Kavin MORGAN, III, Andrew Thomas SCHOLLE, David C. BOM, Hongyang LI

Abstract

An oral care composition is provided and includes a natural flavor extract, a sulfur source such as dimethyl disulfide, a stannous ion source, and a soluble metal ion source that prevents the formation of methyl mercaptan. The natural flavor extract may contain dimethyl disulfide as an impurity. The soluble metal ion source may include a metal salt, a metal oxide, or a combination thereof, and the soluble metal ion source may include a copper ion source, a silver ion source, a zinc ion source, or combinations thereof.

CPC Classifications

A61K 8/19 A61K 8/21 A61K 8/27 A61K 8/46 A61Q 11/00

Filing Date

2025-09-11

Application No.

19325569

View original document →

Named provisions

Inventors Abstract

Classification

Agency
USPTO
Published
September 11th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083649A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Topics
Product Development Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.